EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Decreased Lactococcus lactis and Propionic Acid in Feces of Patients with Moyamoya Disease: Possible Implications of Immune Dysregulation

Mayuko Otomo, Ryosuke Tashiro, Hidetaka Tokuno, Atsushi Kanoke, Keita Tominaga, Arata Nagai, Takashi Aikawa, Daisuke Ando, Hiroyuki Sakata, Takeya Sato, Takaaki Abe, Hidenori Endo und 2 weitere

Cerebrovascular Diseases · 2025

DOI: 10.1159/000545478 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cerebrovascular Diseases, 2025. Verfasst von Mayuko Otomo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Japan. Hauptthemen laut MEDLINE: Feces, Moyamoya Disease, Gastrointestinal Microbiome, Propionates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Moyamoya disease (MMD) is a cerebrovascular disease characterized by progressive steno-occlusive lesions in the terminal portion of the internal carotid artery. Despite its unknown etiology, immune dysregulation is regarded as a critical trigger for delineating the pathophysiology of MMD. The gut microbiota produces short-chain fatty (SCFA) and organic acids, influencing immune regulation and vascular remodeling. We aimed to characterize the gut microbiota in patients with MMD.

Methods

Sixteen patients with MMD and sixteen healthy controls (CON) were included in this study. We performed 16S rRNA sequencing of fecal samples, analyzed microbiome diversity and composition, and quantified SCFA and organic acid levels using liquid chromatography.

Results

There were no significant differences in α- and β-diversities among feces from the MMD patients and CON. However, 16S rRNA sequencing identified defective Lactococcus lactis (0 ± 0 in the MMD patients vs. 0.026 ± 0.084 in healthy CON, p = 0.0181) and abundant Gordinobacter pamelaeae (0.030 ± 0.039 in the patients vs. 0.001 ± 0.005 in healthy CON, p = 0.003) are strongly linked to MMD. Propionic acid levels were significantly lower in feces of the MMD patients compared to healthy CON (0.83 ± 0.34 mg/g in the MMD patients vs. 1.20 ± 0.55 mg/g in healthy CON, p = 0.028).

Conclusion

Decreased L. lactis can result in reduced lactic acid and propionic acid levels in the feces of the patients. This imbalance in the gut microbiome and SCFA/organic acid levels could contribute to immune dysregulation underlying the vascular remodeling seen in MMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FecesMoyamoya DiseaseGastrointestinal MicrobiomePropionatesBacteriaHumansMaleFemaleAdultMiddle AgedCase-Control StudiesRNA, Ribosomal, 16SRibotypingFatty Acids, VolatileYoung Adult

Stichwörter der Autor:innen

Gut dysbiosisLactococcus lactisMoyamoya diseasePropionic acids

Substanzen

propionic acidPropionatesRNA, Ribosomal, 16SFatty Acids, Volatile

Autor:innen und Institutionen

  • Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Japan, ryousuke.tashiro.q2@alumni.tohoku.ac.jp.
  • Department of Neurosurgery, Kohnan Hospital, Sendai, Japan, ryousuke.tashiro.q2@alumni.tohoku.ac.jp.
  • Department of Clinical Biology and Hormonal Regulation, Tohoku University Graduate School of Biomedical Engineering, Sendai, Japan.
  • Department of Neurosurgery, Kohnan Hospital, Sendai, Japan.
  • Department of Neurosurgical Engineering and Translational Neuroscience, Tohoku University Graduate School of Medicine, Sendai, Japan.

Zitieren

APA

Otomo, M., Tashiro, R., Tokuno, H., Kanoke, A., Tominaga, K., Nagai, A., Aikawa, T., Ando, D., Sakata, H., Sato, T., Abe, T., Endo, H., Niizuma, K., & Tominaga, T. (2025). Decreased Lactococcus lactis and Propionic Acid in Feces of Patients with Moyamoya Disease: Possible Implications of Immune Dysregulation. Cerebrovascular Diseases. https://doi.org/10.1159/000545478

Vancouver

Otomo M, Tashiro R, Tokuno H, Kanoke A, Tominaga K, Nagai A, et al. Decreased Lactococcus lactis and Propionic Acid in Feces of Patients with Moyamoya Disease: Possible Implications of Immune Dysregulation. Cerebrovascular Diseases. 2025. doi:10.1159/000545478

BibTeX
@article{Otomo2025,
  author = {Otomo, Mayuko and Tashiro, Ryosuke and Tokuno, Hidetaka and Kanoke, Atsushi and Tominaga, Keita and Nagai, Arata and Aikawa, Takashi and Ando, Daisuke and Sakata, Hiroyuki and Sato, Takeya and Abe, Takaaki and Endo, Hidenori and Niizuma, Kuniyasu and Tominaga, Teiji},
  title = {Decreased Lactococcus lactis and Propionic Acid in Feces of Patients with Moyamoya Disease: Possible Implications of Immune Dysregulation},
  journal = {Cerebrovascular Diseases},
  year = {2025},
  doi = {10.1159/000545478}
}
Kostenlos starten →